(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
I decided to become a single mother by choice. I wasn't ready to stop dating. - 2Four new luxury hotel openings in Italy you need to know about
- 3OPEC’s No. 2 Producer Burns Its Own Gas—Then Buys Iran’s
- 4South Africa pushes for $200B investment
- 5Opening Achievement: 8 Methodologies for Compelling Using time productively
- Track down Your Optimal Conservative Vehicle: Famous Brands to Consider
- Phenomenal Web-based MBA Stages for Proficient Headway
- Find Exemplary Scents: An Extensive Aide
- Why do people have baby teeth and adult teeth?
- Dozens injured in Russia after train crashes, overturns
- I'm a hypnotherapist who helps day traders who are losing money. Here's why I think hypnosis works.
- Floods, Landslides Triggered By Heavy Rain In Afghanistan Leave 77 Dead In 10 days, Authorities Say
- FACT FOCUS: Trump sows confusion on number of childhood vaccinations
- How on earth did 'Shark Tank' star Kevin O'Leary end up in 'Marty Supreme'? I'll let him explain.
